We are live on ! Find out more
SXTP icon

60 Degrees Pharmaceuticals

7 hedge funds and large institutions have $22.5K invested in 60 Degrees Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 77 (0)

0% more ownership

Funds ownership: 0.26%0.26% (+0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

64% less capital invested

Capital invested by funds: $62.9K → $22.5K (-$40.4K)

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$37.3K
2
Citigroup
Citigroup
New York
-$278
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$11.2K +$25.5K +5,513 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$6.33K
TRCT
3
Tower Research Capital (TRC)
New York
$3.42K +$4.17K +900 +115%
Barclays
4
Barclays
United Kingdom
$769 +$1.75K +378 New
UBS Group
5
UBS Group
Switzerland
$750
Osaic Holdings
6
Osaic Holdings
Arizona
$51
Bank of America
7
Bank of America
North Carolina
$16
DS
8
DRW Securities
Illinois
-$37.3K -6,303 Closed
Citigroup
9
Citigroup
New York
-$278 -47 Closed

SXTP Hedge Fund Activity: Q4 2025 in Review

7 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q4 2025, worth a combined $22.5K — down 64% from $62.9K a quarter earlier.

Fund positioning in SXTP was balanced in Q4 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $25.5K. The largest seller was DRW Securities, exiting entirely with an estimated $37.3K sold.

  • 7 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $22.5K of 60 Degrees Pharmaceuticals stock for Q4 2025, down 64% quarter-over-quarter.
  • 2 funds opened new 60 Degrees Pharmaceuticals positions in Q4 2025 and 2 closed out, a net change of 0 holders.
  • The largest 60 Degrees Pharmaceuticals buyer in Q4 2025 was Jane Street, an estimated $25.5K added.
  • The largest 60 Degrees Pharmaceuticals seller in Q4 2025 was DRW Securities, an estimated $37.3K sold.

Based on aggregated 13F filings for Q4 2025.